Trial Profile
Do Residential Aged Care Facilities benefit from oseltamivir treatment of cases plus prophylaxis of contacts, versus oseltamivir treatment of cases alone, with respect to reducing influenza outbreak frequency, duration and complications?
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Therapeutic Use
- 02 Jul 2015 New trial record